PHARMING GRP SP. ADRS (PHG) — Capital Reinvestment Ratio
PHARMING GRP SP. ADRS (PHG) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (€10.71 Million) in capital expenditures (€269.00K). See PHG net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PHARMING GRP SP. ADRS Capital Reinvestment Ratio (2021–2025)
This chart tracks PHARMING GRP SP. ADRS's Capital Reinvestment Ratio across 3 annual periods. Check PHARMING GRP SP. ADRS (PHG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year Capital Reinvestment Ratio for PHARMING GRP SP. ADRS from 2021 to 2025. For live market cap and broader valuation context, see market cap of PHARMING GRP SP. ADRS.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | €54.71 Million | €755.00K | ▼ -84.3% |
| 2022 | 0.09x | €22.46 Million | €1.98 Million | ▼ -80.1% |
| 2021 | 0.44x | €37.84 Million | €16.72 Million | — |